Fundraising Fox
Okomera
Founded 2020 · 24 employees on LinkedIn · 2 known investors
Find your way into Okomera
85 people in our graph share verified history with the Okomera team — schools, employers, funds. One of them is your warm intro.
Mathilde Rousselunlockedknows Raphaël Tomasi · together at WILCO (overlapped)
×3knows the team · via WILCO
knows the team · via ESPCI
×4knows the team · via Institut Pasteur
×3knows the team · via Université Pierre et Marie Curie
Okomera builds a platform combining miniaturized tumor-on-chip technology and AI imaging to analyze patient-derived biopsies and predict personalized drug response for cancer treatment. Its tools serve clinicians and drug developers, spanning drug development to clinical decision-making.
Founders & leadership
Okomera was founded in 2020 by Raphaël Tomasi.
RT
Raphaël TomasiFounder · OkomeraformerCo-founder and CTO of Okomera, where he leads development of an automated droplet microfluidics platform enabling 3D culture and testing of patient cancer cells for precision cancer medicine. He has over 10 years of experience in microfluidics research, with several journal publications and filed patents.
Investors · 2
In the news
Frequently asked questions
- What does Okomera do?
- Okomera builds a platform combining miniaturized tumor-on-chip technology and AI imaging to analyze patient-derived biopsies and predict personalized drug response for cancer treatment. Its tools serve clinicians and drug developers, spanning drug development to clinical decision-making.
- Who founded Okomera?
- Okomera was founded by Raphaël Tomasi in 2020.
- Who are Okomera's investors?
- Okomera's investors include Polytechnique Ventures, Resonance VC.